Axsome Therapeutics Inc (AXSM) stock news · rev $638.5M
Axsome Therapeutics Inc (AXSM) is a biotechnology company listed on US.
This AXSM news page leads with what Axsome Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for AXSM yet. We will not pad this page with generic market recap.
Latest reported AXSM revenue for 2025-12-31 was $638.5M. Net income was -$183.2M. Revenue was up 65.5% from 2024-12-31 to 2025-12-31. AXSM currently screens at market cap $11.96B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the AXSM stock page; for the tape open the quote page.
AXSM stock news FAQ
What are AXSM's latest revenue and net income?
Latest cached Axsome Therapeutics Inc (AXSM) revenue for Dec 31, 2025 was $638.5M. Net income was -$183.2M. Statements: https://lician.com/financials/axsm
How did AXSM revenue change from the prior cached period?
Cached Axsome Therapeutics Inc (AXSM) revenue was up 65.5% from $385.7M (Dec 31, 2024) to $638.5M (Dec 31, 2025). Statements: https://lician.com/financials/axsm
What is AXSM's market cap?
Axsome Therapeutics Inc (AXSM) market cap is $11.96B on the latest cached fundamentals snapshot.
What kind of company is AXSM?
Axsome Therapeutics Inc (AXSM) is a biotechnology company listed on US.
Where is AXSM stock news listed?
Cached stock news for Axsome Therapeutics Inc (AXSM) is listed at https://lician.com/news/axsm. Filings: https://lician.com/sec/axsm
Not investment advice.